Triumph Financial (TFINP) has had the highest return since October 10, 2025 by a US stock, returning 16,070.3%.
| ASSET | % RETURN |
|---|---|
Triumph Financial (TFINP) | 16,070.3% |
180 Life Sciences (ATNF) | 660.18% |
Rani Therapeutics (RANI) | 283.16% |
VisionWave Holdings, Inc Warrant (VWAVW) | 267.39% |
Praxis Precision Medicines (PRAX) | 217.12% |
Australian Oilseeds Holdings Limited Warrant (COOTW) | 180.1% |
Syntec Optics (OPTXW) | 177.16% |
Solidion Technology (STI) | 166.3% |
rYojbaba Co, Ltd Common Shares (RYOJ) | 165.64% |
Kuke Music (KUKE) | 131.67% |
New Era Energy & Digital (NUAIW) | 130.55% |
GCM Grosvenor (GCMGW) | 128.25% |
SCHMID Group NV Warrants (SHMDW) | 123.53% |
enGene Holdings Inc Warrants (ENGNW) | 114.55% |
Scienture (SCNX) | 109.33% |
New Era Energy & Digital (NUAI) | 108.91% |
Aureus Greenway Holdings Inc Common Stock (AGH) | 106.49% |
Australian Oilseeds Holdings Limited Ordinary Shares (COOT) | 105.81% |
error (ZVZZT) | 100.16% |
Sunshine Biopharma Inc Warrant (SBFMW) | 97.96% |
Minerva Neurosciences (NERV) | 94.21% |
A SPAC III Acquisition Corp Right (ASPCR) | 90.74% |
Estrella Immunopharma (ESLA) | 90.4% |
Armata Pharmaceuticals (ARMP) | 89.97% |
Replimune (REPL) | 88.44% |
